Jamroze, A., Zhang, R., Deng, L., Jatwani, K., Ahuja, K., Farmer, B., James, G., Mastri, M., Xu, B., Saenger, Y. M., Yang, Y. A., Krolewski, J., Tang, D., Chatta, G. S., Nastiuk, K. (2026). Optimizing neoadjuvant ADT duration prior to radiotherapy in high-risk prostate cancer: Rationale and clinical need.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.259